Ankylosing Spondylitis

• FDA label_change · 2024-11-21
  FDA Approved: SULINDAC — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental labeling change for sulindac from Actavis Pharma, updating the product labeling under the ANDA. This reflects ad…

• FDA label_change · 2016-09-13
  FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.)

  FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.) indicating a labeling modification related to celecoxib.

• FDA label_change · 2016-01-08
  FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)

  FDA approved a supplemental application for SIMPONI ARIA (golimumab) to update the product labeling.

• FDA label_change · 2015-08-05
  FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)

  FDA approved a supplemental application for Simponi Aria (golimumab) filed by Janssen Biotech, Inc., resulting in changes to the product lab…